PRESENTATION

Q3 2020 — Presentation

Q3 2020PDF · 40 pages23.4 MB
BUSINESS
UPDTE
–Q3 22
© 22 Palanr Technologies Inc.	November 22

-- 1 of 40 --

Safe Harbor
This presentaon and the accompanying oral commentary contain “forward-looking” statements within the meaning of the federal securies laws, and these statements involve substanal risks and uncertaines. All statements other than statements of
historical fact could be deemed forward-looking, including, but not limited to, expectaons of future operang results or financial performance, market size and growth opportunies, the calculaon of certain of our key financial and operang metrics, plans for
future operaons, compeve posion, technological capabilies, and strategic relaonships, as well as assumpons relang to the foregoing. Forward-looking statements are inherently subject to risks and uncertaines, some of which cannot be predicted or
quanfied. In some cases, you can idenfy forward-looking statements by terminology such as “guidance,” “expect,” “ancipate,” “should,” “believe,” “hope,” “target,” “project,” “plan,” “goals,” “esmate,” “potenal,” “predict,” “may,” “will,” “might,” “could,”
“intend,” “shall,” and variaons of these terms or the negave of these terms and similar expressions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or
results and will not necessarily be accurate indicaons of the mes at, or by, which such performance or results will be achieved, if at all.
Forward-looking statements are subject to a number of risks and uncertaines, many of which involve factors or circumstances that are beyond our control. Our actual results could differ materially from those stated or implied in forward-looking statements due
to a number of factors, including but not limited to risks detailed in our filings with the Securies and Exchange Commission (the “SEC”), including in our prospectus filed with the SEC pursuant to Rule 424(b), dated September 22, 2020, our quarterly report on
Form 10-Q for the quarter ended September 30, 2020, and other filings and reports that we may file from me to me with the SEC. You can locate these reports on our investor relaons website (hps://investors.palanr.com/financials/sec-filings/) or on the
SEC website (www.sec.gov). If the risks or uncertaines ever materialize or the assumpons prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. Except as required by law, we assume no
obligaon and do not intend to update these forward-looking statements or to conform these statements to actual results or to changes in our expectaons.
We use the non-GAAP financial measures contribuon margin; gross profit and gross margin, excluding stock-based compensaon; and adjusted operang income (loss) and adjusted operang margin to help us evaluate our business, idenfy trends affecng
our business, formulate business plans and financial projecons, and make strategic decisions. Our definions may differ from the definions used by other companies and therefore comparability may be limited. In addion, other companies may not publish
these or similar metrics. Further, these metrics have certain limitaons in that they do not include the impact of certain expenses that are reflected in our consolidated statement of operaons. Thus, these non-GAAP financial measures should be considered in
addion to, not as a substute for, or in isolaon from, measures prepared in accordance with GAAP.
We compensate for these limitaons by providing reconciliaons of these non-GAAP financial measures to the most comparable GAAP measures. We encourage investors and others to review our business, results of operaons and financial informaon in its
enrety, not to rely on any single financial measure, and to view these non-GAAP financial measures in conjuncon with the most directly comparable GAAP financial measures.
This presentaon contains stascal data, esmates and forecasts that are based on independent industry publicaons or other publicly available informaon, as well as other informaon based on our internal sources. This informaon involves many
assumpons and limitaons, and you are cauoned not to give undue weight to these esmates. We have not independently verified the accuracy or completeness of the data contained in these industry publicaons and other publicly available informaon.
Accordingly, we make no representaons as to the accuracy or completeness of that data nor do we undertake to update such data after the date of this presentaon.
This presentaon also contains links to publicly-available websites, data, or other informaon. We have not independently verified the accuracy or completeness of such websites, data, or informaon and accordingly we make no representaons as to their
accuracy or completeness nor do we undertake to update such data or informaon after the date of this presentaon. The inclusion of external links does not constute endorsement by Palanr of the linked websites or the data or informaon contained therein.
By aending or receiving this presentaon you acknowledge that you will be solely responsible for your own assessment of the market and our market posion and that you will conduct your own analysis and be solely responsible for forming your own view of the
potenal future performance of our business.
Any non-Palanr logos or trademarks included herein are the property of the owners thereof and are used for reference purposes only. Such use should not be construed as an endorsement of the platform and products of Palanr.

-- 2 of 40 --

Congratulaons to the
U.S. Jusce Department
on its selement with
Purdue Pharma and
fight against the Opioid
epidemic in America.
Supporng the Department of Jusce
with Palanr Gotham
Jusce Department Announces Global
Resoluon of Criminal and Civil
Invesgaons with Opioid Manufacturer
Purdue Pharma and Civil Selement
with Members of the Sackler Family
OCT 21, 22
DEPRTMENT OF JUSTCE–OFFCE OF PUBLC FFRS
Yuri Gripas/AFP via Gey Images
RED MORE ↗

-- 3 of 40 --

Congratulaons to the
World Food Programme
on its Nobel Peace Prize.
Supporng WFP with Palanr Foundry
World Food Programme
UN World Food Programme wins 2020
Nobel Peace Prize, as hunger mounts
OCT 9, 22
UN NES–PECE ND SECURT
RED MORE ↗

-- 4 of 40 --

U.S. Army photo by Staff Sgt. Marcus Fichtl
In awe of and grateful
for the service of our
Special Operators.
October's rescue is
yet another amazing
accomplishment -
one that often goes
unrecognized.
Supporng Special Operators
U.S. Special Operaons Forces
Rescue American Hostage In Nigeria
OCT 31, 22
NPR–ORLD
RED MORE ↗

-- 5 of 40 --

Adjusted operang income (loss) and adjusted operang margin exclude stock-based compensaon, employer taxes related to stock-based compensaon,
and expenses primarily related to the direct lisng. Refer to the Appendix for reconciliaons of these non-GAAP financial measures to the most directly
comparable GAAP financial measures.
Q3 2020 Financial Highlights
Revenue
FG 1
REENUE
Q3 219 	Q3 22
$191M
$289M
+52%
Adjusted Operang Income (Loss)
FG 2
DJUSTED OPERTNG NCOME (LOSS)
Q3 219 	Q3 22
($92M)
$73M
25%
(48%)
DJUSTED OPERTNG MRGN

-- 6 of 40 --

COVID-19 forced instuons to
transform quickly in order to survive.
We are helping those customers
do more with less.
RED MORE ↗
RED MORE ↗

-- 7 of 40 --

An energy supermajor deployed our ERP suite in hours.
Within two weeks, they generated $57 million of cash savings
and expect to generate $1 billion on an annualized basis.
All data is noonal.
RED MORE ↗
TCH DEO ↗

-- 8 of 40 --

All data is noonal.
$3 million
FE-ER RENEL
An aerospace customer
signed the largest
commercial deal
we’ve ever done in the
midst of a pandemic
that shook their
enre industry.
TCH DEO 	↗

-- 9 of 40 --

All data is noonal.
A Fortune 100 consumer goods company deployed ERP Suite to
quickly respond to COVID-related disruptions. Now, our platforms are
connecting the entire value chain – from procurement to distribution.

-- 10 of 40 --

All data is noonal.
A top 5 pharmaceucal
company is linking data
from more than 2,000
clinical trials in Foundry
to uncover trends across
trials and securely
analyze outcomes at
a populaon level.

-- 11 of 40 --

Our software is becoming the de facto
operang system of US and Allied Defense.
RED MORE ↗

-- 12 of 40 --

Signed a two-year, $91 million contract
with the U.S. Army Research Laboratory.
All data is noonal.
U.S. Army Research Lab Selects
Palanr Technologies Inc. for
$91M Arficial Intelligence and
Machine Learning Development
OCT 1, 22
BUSNESS RE
RED MORE ↗
RED MORE ↗

-- 13 of 40 --

All data is noonal.
Scaled from an all-domain Common
Operang Picture (COP) at the onset
of COVID-19 to the JADC2 doctrinal
paradigm across all mission areas
Inform accurate Course of Acon
(COA) development with integrated
operaonal readiness data
Use AI to evaluate COAs and answer
complex paern-of-life quesons
in seconds, not hours
Enabling Mission
Command for NORAD
& USNORTHCOM
(N / NC) Joint
All-Domain Command
& Control (JADC2)

-- 14 of 40 --

Our software is becoming the infrastructure
for the U.S. healthcare system – from R&D
to distribuon, from public to private.

-- 15 of 40 --

Signed a $36 million contract to support NCATS efforts, including
cancer research, COVID-19 research, and PEPFAR.
All data is publicly available at hps://covid.cd2h.org/enclave_projects
NIH expanding enclave for COVID-19
data with $36M Palanr contract
SEP 29, 22
FEDSCOOP–CQUSTON
RED MORE ↗
RED MORE ↗

-- 16 of 40 --

All data is publicly available at hps://covid.cd2h.org/enclave_projects
The ambious effort to piece together
America’s fragmented health data
OCT 19, 22
THE ERGE
RED MORE ↗
Powering N3C / UNITE,
an effort from NIH
to collaborate with
clinical and research
instuons.
NIH’s N3C is the largest COVID-19
clinical data asset in the world, with over
1 million paents across more than 30
hospitals — all assembled in Foundry
in less than 5 months.
WTCH VIDEO ↗

-- 17 of 40 --

RED MORE ↗
Supporng the
complex supply chain
and logiscs for
COVID-19 vaccine
distribuon.
Palanr to Help U.S. Track Covid-19 Vaccines
OCT 22, 22
LL STREET JOURNL–BUSNESS
RED MORE ↗

-- 18 of 40 --

We are powering secure cross-border collaboraon
for pandemic response and beyond.

-- 19 of 40 --

RED MORE ↗
Powering the NHS England’s allocaon and distribuon of
more than 2.7 billion pieces of PPE, from port to paent.
All data is noonal.

-- 20 of 40 --

All data is noonal.
Supporng the President of Colombia
through the naon’s pandemic response.
RED MORE ↗

-- 21 of 40 --

FNNCL
UPDTE
© 22 Palanr Technologies Inc.

-- 22 of 40 --

Revenue
FG 3
REENUE
Q3 219 	Q3 22
$191M
$289M
+52%
We grew our revenue
by 52% year-over-year
in Q3 2020. GROTH

-- 23 of 40 --

We connue to grow
exisng contracts as
our customers derive
more value from their
software subscripons.
Average Revenue
Per Customer
FG 4
ERGE REENUE
Average Revenue
of Top 20 Customers
FG 5
ERGE REENUE	GROTH 	GROTH
9 MONTHS ENDED
SEPTEMBER 3, 219
9 MONTHS ENDED
SEPTEMBER 3, 22
$4.2M
$5.8M
+38%
9 MONTHS ENDED
SEPTEMBER 3, 219
9 MONTHS ENDED
SEPTEMBER 3, 22
$17.4M
$23.6M
We define a customer as an organizaon from which we have recognized revenue in a reporng period. For large government agencies, where a single instuon has mulple divisions, units,
or subsidiary agencies, each such division, unit, or subsidiary agency that enters into a separate contract with us and is invoiced as a separate enty is treated as a separate customer.
+36%

-- 24 of 40 --

Q3 219 	Q3 22
($92M)
$73M
(48%)
25%
Adjusted Operang Income (Loss)
FG 6
DJUSTED OPERTNG NCOME (LOSS)
Our adjusted operang
income in Q3 2020 was
$73 million, and adjusted
operang margin was 25%.
DJUSTED OPERTNG MRGN
Adjusted operang income (loss) excludes stock-based compensaon, expenses primarily related to our direct lisng, and employer payroll taxes related to stock-based compensaon.
Refer to the Appendix for reconciliaons of these non-GAAP financial measures to the most directly comparable GAAP measures.

-- 25 of 40 --

9 MONTHS ENDED SEPTEMBER 3, 219 	9 MONTHS ENDED SEPTEMBER 3, 22
Revenue from our
top 20 customers
connues to grow,
while customer
concentraon is
decreasing.
FG 7 	FG 8
In the 9 months ended
September 30, 2019, revenue
from our top 20 customers
comprised 68% of total revenue.
In the 9 months ended
September 30, 2020, revenue
from our top 20 customers
comprised 61% of total revenue.
$348M
$471M
REENUE FROM TOP 20 CUSTOMERS 	REENUE FROM TOP 20 CUSTOMERS

-- 26 of 40 --

$94M
$127M
$94M
+35%
$300 million license renewal in the
aerospace industry starng in 2021
New deals across a variety of vercals,
including consumer goods, healthcare,
and financial services
In Q3 2020, our
commercial business
grew 35% year-over-year,
and we signed the
largest commercial
deal in our history.
Commercial Revenue
FG 9
GROTH	REENUE
Q3 219 	Q3 22

-- 27 of 40 --

$163M
$97M
+68%
In Q3 2020, our
government business
grew 68% year-over-year.
Government Revenue
FG 1
GROTH	REENUE
Q3 219 	Q3 22
Two-year, $91 million contract with the
U.S. Army Research Laboratory
$36 million, IDIQ award with the Naonal
Center for Advancing Translaonal Sciences
RED MORE ↗
RED MORE ↗

-- 28 of 40 --

Acquire Phase
FG 11
Expand Phase
FG 12
Scale Phase
FG 13
REENUE
CONTRBUTON
REENUE
CONTRBUTON MRGN
REENUE
CONTRBUTON MRGN
We accelerated growth in all three phases of our business model.
$19M
$41M
($14M) ($4M)
$161M
$254M
35%
41%
$296M
$452M
68%
69%
6 MONTHS ENDED
JUNE 3, 22
9 MONTHS ENDED
SEPTEMBER 3, 22
6 MONTHS ENDED
JUNE 3, 22
9 MONTHS ENDED
SEPTEMBER 3, 22
6 MONTHS ENDED
JUNE 3, 22
9 MONTHS ENDED
SEPTEMBER 3, 22

-- 29 of 40 --

$22.8M
$8.3M
+175%
In addion to customers
accounted for by our
three-phase model,
revenue from customers
acquired in the 9 months
ended September 30,
2020 grew by 175%
year-over-year.
GROTH	REENUE
FG 14
Revenue from Customers Acquired in the
9 Months Ended September 30, 2019 and 2020
We are signing up new customers
and converng them to significant
revenue-generang posions
in record me.
9 MONTHS ENDED
SEPTEMBER 3, 219
9 MONTHS ENDED
SEPTEMBER 3, 22
The customers acquired in the nine months ended September 30, 2019 were not in a cohort as of December 31, 2018, and were assigned a cohort as of December 31, 2019.
The customers acquired in the nine months ended September 30, 2020 were not in a cohort as of December 31, 2019, and will be assigned a cohort as of December 31, 2020.

-- 30 of 40 --

Gross margin, excluding stock-based compensaon, is a non-GAAP financial measure. Refer to the Appendix for
reconciliaons of this non-GAAP financial measure to the most directly comparable GAAP measure.
81%
7%
Our gross margin,
excluding stock-based
compensaon,
was 81%, up from
70% in Q3 2019.
Gross Margin, Excluding Stock-Based Compensaon
FG 15
Q3 219 	Q3 22
GROSS MRGN, EXCLUDNG STOCK-BSED COMPENSTON

-- 31 of 40 --

We have strong and
increased visibility into
future revenue across
our customer base.
We calculate expected average contract
duraon on a dollar-weighted basis.
Expected average duraon includes exisng contractual obligaons and assumes that our customers exercise all of the contractual opons available to them and do not terminate for convenience.
Expected Average Contract Duraon
FG 16
EXPECTED ERGE DURTON (ERS)
3.5
3.6
Q2 22 	Q3 22

-- 32 of 40 --

We connue to have a strong balance sheet.
$1.8B
Cash and cash equivalents as of September 30, 2020

-- 33 of 40 --

GUDNCE
© 22 Palanr Technologies Inc.

-- 34 of 40 --

With strong visibility into
future revenue and the
connued acceleraon
of our business, we are
raising our full-year
2020 revenue and
adjusted operang
income guidance.
2020 Revenue
Guidance
FG 17
2020 Adjusted Operang
Income Guidance
FG 18
GUDNCE
GROTH
22
$1.71B
+44%
22
$133M
12%
GUDNCE
DJUSTED OPERTNG MRGN
Adjusted operang income excludes stock-based compensaon and employer payroll taxes related to stock-based compensaon as well as direct lisng related costs. A reconciliaon of adjusted operang income to the corresponding GAAP measure is not available on a forward-looking basis
without unreasonable effort due to the uncertainty regarding, and the potenal variability of, reconciling items that may be incurred in the future such as stock-based compensaon, and employer payroll taxes related to stock-based compensaon, the effect of which may be significant.
For 2020 guidance, numbers reflect the midpoint of the esmated range for such measures.

-- 35 of 40 --

GUDNCE
GROTH
GUDNCE
DJUSTED OPERTNG MRGN
We are expecng
31% revenue growth
in Q4 2020, and
year-over-year
revenue growth to
be greater than
30% through 2021.
Q4 2020
Revenue
Guidance
FG 19
Q4 2020 Adjusted
Operang Income
Guidance
FG 2
Adjusted operang income excludes stock-based compensaon and employer payroll taxes related to stock-based compensaon as well as direct lisng related costs. A reconciliaon of adjusted operang income to the corresponding GAAP measure is not available on a forward-looking basis
without unreasonable effort due to the uncertainty regarding, and the potenal variability of, reconciling items that may be incurred in the future such as stock-based compensaon, and employer payroll taxes related to stock-based compensaon, the effect of which may be significant.
For Q4 2020 guidance, numbers reflect the midpoint of the esmated range for such measures.
Q4 22
$3M
+31%
Q4 22
$47M
16%

-- 36 of 40 --

PPENDX
© 22 Palanr Technologies Inc.

-- 37 of 40 --

All figures in reconciliaon tables are unaudited. The tables present direct or indirect reconciliaons of the selected non-GAAP financial measures to the most comparable GAAP financial measures.
($k)
Gross Profit
Add: Stock-Based Compensaon
Gross Profit, Excluding Stock-Based Compensaon
$125,468
$7,183
Q3 2019
$132,651
7%
$140,026
$94,385
Q3 2020
$234,411
81%	Gross Margin, Excluding Stock-Based Compensaon
Reconciliaon of Gross Profit to Gross Profit and
Gross Margin, Excluding Stock-Based Compensaon

-- 38 of 40 --

Reconciliaon of Loss from Operaons to Contribuon Margin
All figures in reconciliaon tables are unaudited. The tables present direct or indirect reconciliaons of the selected non-GAAP financial measures to the most comparable GAAP financial measures.
($k)
Loss from Operaons
Add:
Research and Development Expenses, Excluding Stock-Based Compensaon
General and Administrave Expenses, Excluding Stock-Based Compensaon
Stock-Based Compensaon
Contribuon
($169,33)
6 MONTHS ENDED JUNE 3, 22
$231,636
48%
($1,17,17)
$99,686 	$156,832
$119,325 	$226,455
$181,955 	$1,28,914
9 MONTHS ENDED SEPTEMBER 3, 22
$395,94
51%	Contribuon Margin

-- 39 of 40 --

Reconciliaon of Loss from Operaons to
Adjusted Operang Income (Loss) and Adjusted Operang Margin
All figures in reconciliaon tables are unaudited. The tables present direct or indirect reconciliaons of the selected non-GAAP financial measures to the
most comparable GAAP financial measures. Non-recurring charges includes charges related to the Direct Lisng and public company readiness iniaves.
($k)
Loss from Operaons
Add:
Stock-Based Compensaon and Related Employer Payroll Taxes
Non-Recurring Charges
Adjusted Operating Income (Loss)
Adjusted Operang Margin
($144,14)
Q3 2019
($92,377)
($847,777)
$51,763 	$867,131
– 	$53,737
Q3 2020
$73,91
(48%) 	25%

-- 40 of 40 --